tiprankstipranks
Trending News
More News >
Alterity Therapeutics Ltd. (AU:ATH)
ASX:ATH
Australian Market

Alterity Therapeutics (ATH) Share Forecast & Price Target

Compare
34 Followers
See the Price Targets and Ratings of:

ATH Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Alterity
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ATH Stock 12 Month Forecast

There Are No Analyst Ratings for AU:ATH In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ATH Financial Forecast

ATH Earnings Forecast

The previous quarter’s earnings for ATH were AU$0.00.
The previous quarter’s earnings for ATH were AU$0.00.
No data currently available

ATH Sales Forecast

The previous quarter’s earnings for ATH were AU$0.00.
The previous quarter’s earnings for ATH were AU$0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on AU:ATH
Canaccord Genuity
Canaccord Genuity
AU$0.01
Buy
0.00%
Upside
Reiterated
12/17/25
Canaccord Genuity Sticks to Their Buy Rating for Alterity Therapeutics (PRNAF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on AU:ATH
Canaccord Genuity
Canaccord Genuity
AU$0.01
Buy
0.00%
Upside
Reiterated
12/17/25
Canaccord Genuity Sticks to Their Buy Rating for Alterity Therapeutics (PRNAF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ATH Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
0
1
1
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
1
1
1
0
In the current month, ATH has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ATH average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ATH Stock Forecast FAQ

What is AU:ATH’s average 12-month price target, according to analysts?
Currently, no data Available
What is AU:ATH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AU:ATH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Alterity Therapeutics Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is Alterity Therapeutics Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about Alterity Therapeutics Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Alterity Therapeutics Ltd.?
      To buy shares of AU:ATH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.